Report shows how the FDA incorporates the two ISO standards in its medical device development policy, how the EU version of the two standards differs in significant ways and how the EU Medical Device Regulation may require further changes in the European standards.
In an effort to deepen Ohio’s biotech footprint, a state economic development initiative is pouring more $12.8 million into cutting-edge biomedical companies, startups and entrepreneurs to support innovation in the state. Read More
Pfizer will allow Teva to launch a generic of Viagra in the U.S. in 2017 — more than two years before the final patent on the drug expires — under a deal that settles a long-running patent flap. Read More